Research reveals how key controller protein is switched on

Jul 10, 2014

New research has uncovered how a complex protein pivotal in the development of cancer, viral infection and autoimmune diseases is activated. The discovery answers a key question about one of the most widely-researched proteins in human biology, which has been the subject of tens of thousands of research papers and millions of pounds in research funding.

Jiazhen Zhang, a research student in Professor Sir Philip Cohen's laboratory at the University of Dundee, uncovered how the complex, called NF-κB, is activated. The results are published today in the Biochemical Journal.

NF-κB (nuclear factor kappa-light-chain-enhancer of activated B cells) is a that controls transcription of DNA. NF-κB is found in almost all animal cell types and plays a key role in regulating the immune response to infection. Incorrect regulation of NF-κB has been linked to cancer, inflammatory, and , septic shock, viral infection, and improper immune development.

"NF-κB has been the subject of a vast amount of research for many years as it plays a critical role in and cancer," said Sir Philip. "It has been known for some time that the protein is activated by a kinase called IKKβ but there has been split opinion with regards to how the kinase itself is switched on.

"We have confirmed that another kinase, TAK1, is involved, but surprisingly it isn't sufficient to switch on IKKβ. Two other events need to happen in addition, namely the formation of an unusual type of ubiquitin chain and its attachment to IKKβ and then the addition of a second phosphate group on to IKKβ which remarkably is carried out by IKKβ itself. It is only then that IKKβ becomes competent to switch on NF-κB.

"This is complex biochemistry but working out the details of how proteins are switched on and off is how new ways to develop improved drugs to treat disease are identified. For example, the enzyme that makes the ubiquitin chains needed to activate IKKβ could now be targeted to develop a drug to treat inflammatory diseases."

The research was carried out in the Medical Research Council Protein Phosphorylation and Ubiquitylation Unit (MRC-PPU) at Dundee.

Peter Shepherd, Chair of the Biochemical Journal Editorial Board, said, "This signalling pathway is critical for a wide range of cellular responses, particularly stress responses. Understanding how this pathway is regulated is hugely important, and this paper finally clarifies one of the key steps in this process. This is important in not only understanding the disease process, but in the quest to develop new therapies that target this signalling pathway."

Explore further: Linking vascular inflammation to obesity and atherosclerosis

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

Nature inspires a greener way to make colorful plastics

14 hours ago

Long before humans figured out how to create colors, nature had already perfected the process—think stunning, bright butterfly wings of many different hues, for example. Now scientists are tapping into ...

New catalyst converts carbon dioxide to fuel

16 hours ago

Scientists from the University of Illinois at Chicago have synthesized a catalyst that improves their system for converting waste carbon dioxide into syngas, a precursor of gasoline and other energy-rich products, bringing ...

Bullet 'fingerprints' to help solve crimes

16 hours ago

Criminals don't just have to worry about their own fingerprints these days: because of a young forensic scientist at The University of Western Australia, they should also be very concerned about their bullets' ...

User comments : 0